China Mesalazine Market to Surpass US$ 65.9 Mn by 2030| Coherent Market Insights
![]() |
China Mesalazine Market |
A medication called Mesalamine,
commonly referred to as Mesalazine, is used to treat ulcerative
colitis, a disorder that causes swelling and ulcers in the rectum and colon
lining. In addition to relieving symptoms, they continue to alleviate
ulcerative colitis symptoms. Mesalamine belongs to the class of drugs known as
anti-inflammatory medicines and is the active component of sulfasalazine, which
is metabolised to produce sulfapyridine and mesalazine.
Rectal Bleeding Is A Significant Driver Driving China
Mesalazine Market Revenue
Growth, Along With Increased Usage Of Mesalamine For The Treatment Of
Ulcerative Colitis, Continuing Improvement In Colon And Rectum Inflammation,
And Administration As A Treatment For Diarrhoea.
China Mesalazine Market
Is Estimated To Be Valued At US$ 51.6 Million In 2022 And Is Expected To
Exhibit A CAGR Of 3.1% During The Forecast Period (2022-2030).
It is a component of the prodrug balsalazide and an active
component of the inert carrier molecule 4-aminobenzoyl-beta-alanine. It is a
member of the group of medications known as Disease-Modifying Antirheumatic
Drugs (DMARDs). Typically thought to be relatively safe and well tolerated by
patients with few to no side effects, it works by preventing the body from
producing a certain chemical that may induce inflammation.
Due to its anti-inflammatory properties, the product has
increased in popularity as a treatment for ulcerative colitis, which is a major
contributor in the China Mesalazine
Market revenue
growth. Inflammatory bowel diseases (IBD) are digestive disorders that harm the
lining of the large intestine and rectum, resulting in severe pain and
discomfort, inflammation, ulcers, and sores.
The drug aids in lowering inflammation, bringing down a
corresponding fever, and relieving pain quickly. They also aid in the treatment
of chronic pain issues brought on by IBD, such as headaches, sprains, and
strains. Additionally, a rise in inflammatory colitis cases with excruciating
symptoms boosts hospital usage and fuels China Mesalazine
Market revenue
growth over the course of the forecast period.
Comments
Post a Comment